ECSTACY: A Review of MDMA and MDA

  title={ECSTACY: A Review of MDMA and MDA},
  author={R. Climko and H. Roehrich and D. Sweeney and J. Alrazi},
  journal={The International Journal of Psychiatry in Medicine},
  pages={359 - 372}
  • R. Climko, H. Roehrich, +1 author J. Alrazi
  • Published 1986
  • Medicine
  • The International Journal of Psychiatry in Medicine
  • The Drug Enforcement Administration classified the drug methylenedioxymeth-amphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl… CONTINUE READING
    71 Citations

    Figures and Topics from this paper

    An Exploration of the History and Controversies Surrounding MDMA and MDA
    • A. R. Pentney
    • Psychology, Medicine
    • Journal of psychoactive drugs
    • 2001
    • 63
    3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
    • 183
    The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
    • H. Kalant
    • Medicine
    • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
    • 2001
    • 511
    • PDF
    M.D.M.A. (“Ecstasy”); a case of possible drug-induced psychosis
    • 21
    • PDF
    3 , 4-Methylenedioxy analogues of amphetamine : Defining the risks to humans
    • 4
    • PDF


    Another abusable amphetamine.
    • 32
    Fatal intoxication from 3,4-methylenedioxyamphetamine.
    • 25
    PMA deaths in Ontario.
    • G. Cimbura
    • Medicine
    • Canadian Medical Association journal
    • 1974
    • 63
    MDA: a psychoactive agent with dual stimulus effects.
    • 48